These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 541858)

  • 1. [Studies of antithrombin III assay using new chromogenic peptide substrates (author's transl)].
    Asai K; Takagi A; Inagaki Y; Setsuda Y
    Rinsho Byori; 1979 Dec; 27(12):1121-5. PubMed ID: 541858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of two-stage antithrombin III assay using new chromogenic peptide substrates (author's transl)].
    Asai K; Takagi A; Otsubo M
    Rinsho Byori; 1980 Jan; 28(1):76-80. PubMed ID: 7373879
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assay of antithrombin III activity using chromogenic substrate (author's transl)].
    Koresawa S; Matsuda N; Ueda S
    Rinsho Byori; 1982 Jan; 30(1):54-8. PubMed ID: 7087231
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the determination of plasma antithrombin III with chromogenic peptide substrate (author's transl)].
    Nakamura S; Takizawa N; Nakanishi K; Igarashi M
    Rinsho Byori; 1980 Jan; 28(1):81-6. PubMed ID: 7373880
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of colorimetric, fluorometric and spectrophotometric methods for measuring antithrombin III using synthetic substrates].
    Uete T
    Rinsho Byori; 1984 Nov; 32(11):1258-62. PubMed ID: 6520982
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assay of antithrombin III and soluble fibrin complexes in the study of blood thrombophilia (author's transl)].
    Colombo LA; Corberi OM; Finzi M; Rossi G
    Chir Ital; 1979 Aug; 31(4):650-61. PubMed ID: 553732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of urinary kallikrein assay by using chromogenic peptide substrates (I) (author's transl)].
    Irie A; Kokawa M; Kadono K; Kushiro H; Kodama J
    Rinsho Byori; 1981 Apr; 29(4):419-22. PubMed ID: 6915116
    [No Abstract]   [Full Text] [Related]  

  • 9. [Assays of antithrombin III by bioimmunologic methods (author's transl)].
    Marchesi NR; Albina RM; Castuma JC; Paolicchi DR; Bergna LJ
    Sangre (Barc); 1979; 24(2):199-204. PubMed ID: 380024
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)].
    Hesse R; Tritschler W; Castelfranchi G; Bablok W
    Blut; 1981 Apr; 42(4):227-34. PubMed ID: 7225580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III during pregnancy and puerperium (author's transl)].
    Torner C; Leroy B; Fouche F; Perles R
    Nouv Presse Med; 1979 Jan; 8(1):46. PubMed ID: 554062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antithrombin III: the correlation structure-function in healthy people and in cirrhotic patients (author's transl)].
    Vicente JM; Díaz Cremades JM; Borrell M; Felez J; Gimferrer E; Pujol N; Domingo A; Rutllant ML
    Sangre (Barc); 1978; 23(5):544-53. PubMed ID: 368998
    [No Abstract]   [Full Text] [Related]  

  • 13. [Latex agglutination method for measurement of antithrombin III in human plasma (author's transl)].
    Fujisawa M; Koyahara I; Yamasaki K; Namba S; Matsuda T; Murakami M
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):898-906. PubMed ID: 7234302
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238.
    van Voorthuizen H; Kluft C
    Thromb Haemost; 1984 Dec; 52(3):350-3. PubMed ID: 6531759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison between anticoagulant activity and antigenicity of plasma antithrombin III in healthy subjects and patients with disseminated intravascular coagulation (DIC) (author's transl)].
    Matsuda T; Ogawara M; Miura R; Seki T; Yokouchi M; Murakami M; Fujisawa M; Nakanishi K; Nakamura S
    Rinsho Ketsueki; 1980 Mar; 21(3):341-6. PubMed ID: 6157843
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antithrombin III assay using a chromogenic substrate in newborns].
    De Mattia D; Montagna O; Marvulli E
    Boll Soc Ital Biol Sper; 1979 Apr; 55(8):746-50. PubMed ID: 554643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of antithrombin III in human aqueous humor (author's transl)].
    Schmut O; Hofmann H
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 May; 210(3):219-21. PubMed ID: 116567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the determination of prothrombin with chromogenic peptide substrate (author's transl)].
    Nakamura S; Takizawa N; Nakanishi K; Igarashi M
    Rinsho Byori; 1980 Feb; 28(2):153-7. PubMed ID: 7366016
    [No Abstract]   [Full Text] [Related]  

  • 19. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
    Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.